Trials / No Longer Available
No Longer AvailableNCT02300753
Emergency Administration of EPI-743 to a Single Patient With Leber's Hereditary Optic Neuropathy [LHON]
- Status
- No Longer Available
- Phase
- —
- Study type
- Expanded Access
- Enrollment
- —
- Sponsor
- Edison Pharmaceuticals Inc · Industry
- Sex
- All
- Age
- 8 Years – 65 Years
- Healthy volunteers
- —
Summary
Expanded access Protocol to treat LHON subjects with EPI743
Detailed description
Emergency use administration of EPI-743 to subjects with LHON. This Protocol was originally developed to treat a single subject but was expanded to treat several at a single institution.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | EPI-743 | EPI-743 is a quinone oxidation product of alpha-tocotrienol |
Timeline
- First posted
- 2014-11-25
- Last updated
- 2014-11-25
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02300753. Inclusion in this directory is not an endorsement.